The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Apoptosis Assays Market Research Report 2024

Global Apoptosis Assays Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1890562

No of Pages : 95

Synopsis

Apoptosis (programmed cell death) is the genetically controlled ablation of cells during normal development. Apoptosis is distinct from necrosis in both the biochemical and the morphological changes that occur. In contrast to necrotic cells, apoptotic cells are characterized morphologically by compaction of the nuclear chromatin, shrinkage of the cytoplasm and production of membrane-bound apoptotic bodies.

The global Apoptosis Assays market was valued at US$ 3222.4 million in 2023 and is anticipated to reach US$ 4852.5 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.

North American market for Apoptosis Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Apoptosis Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Apoptosis Assays in Drug Discovery & Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Apoptosis Assays include Merck, Thermo Fisher Scientific, Becton Dickinson, Bio-Rad Laboratories, Promega Corporation, Abcam, Bio-Techne, Sartorius and Biotium, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Apoptosis Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apoptosis Assays.

Report Scope

The Apoptosis Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apoptosis Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Apoptosis Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Merck
  • Thermo Fisher Scientific
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Promega Corporation
  • Abcam
  • Bio-Techne
  • Sartorius
  • Biotium
  • Creative Bioarray
  • Geno Technology
  • GeneCopoeia
  • Danaher
  • GE Healthcare
  • PerkinElmer

Segment by Type

  • Caspase Assays
  • Annexin V and Cell Permeability Assays
  • DNA Fragmentation Assays
  • Mitochondrial Assays

Segment by Application

  • Drug Discovery & Development
  • Clinical & Diagnostic Applications
  • Basic Research
  • Stem Cell Research

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Apoptosis Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Apoptosis Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Caspase Assays
1.2.3 Annexin V and Cell Permeability Assays
1.2.4 DNA Fragmentation Assays
1.2.5 Mitochondrial Assays
1.3 Market by Application
1.3.1 Global Apoptosis Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery & Development
1.3.3 Clinical & Diagnostic Applications
1.3.4 Basic Research
1.3.5 Stem Cell Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Apoptosis Assays Market Perspective (2019-2030)
2.2 Apoptosis Assays Growth Trends by Region
2.2.1 Global Apoptosis Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Apoptosis Assays Historic Market Size by Region (2019-2024)
2.2.3 Apoptosis Assays Forecasted Market Size by Region (2025-2030)
2.3 Apoptosis Assays Market Dynamics
2.3.1 Apoptosis Assays Industry Trends
2.3.2 Apoptosis Assays Market Drivers
2.3.3 Apoptosis Assays Market Challenges
2.3.4 Apoptosis Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Apoptosis Assays Players by Revenue
3.1.1 Global Top Apoptosis Assays Players by Revenue (2019-2024)
3.1.2 Global Apoptosis Assays Revenue Market Share by Players (2019-2024)
3.2 Global Apoptosis Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Apoptosis Assays Revenue
3.4 Global Apoptosis Assays Market Concentration Ratio
3.4.1 Global Apoptosis Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Apoptosis Assays Revenue in 2023
3.5 Apoptosis Assays Key Players Head office and Area Served
3.6 Key Players Apoptosis Assays Product Solution and Service
3.7 Date of Enter into Apoptosis Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Apoptosis Assays Breakdown Data by Type
4.1 Global Apoptosis Assays Historic Market Size by Type (2019-2024)
4.2 Global Apoptosis Assays Forecasted Market Size by Type (2025-2030)
5 Apoptosis Assays Breakdown Data by Application
5.1 Global Apoptosis Assays Historic Market Size by Application (2019-2024)
5.2 Global Apoptosis Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Apoptosis Assays Market Size (2019-2030)
6.2 North America Apoptosis Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Apoptosis Assays Market Size by Country (2019-2024)
6.4 North America Apoptosis Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Apoptosis Assays Market Size (2019-2030)
7.2 Europe Apoptosis Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Apoptosis Assays Market Size by Country (2019-2024)
7.4 Europe Apoptosis Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Apoptosis Assays Market Size (2019-2030)
8.2 Asia-Pacific Apoptosis Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Apoptosis Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Apoptosis Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Apoptosis Assays Market Size (2019-2030)
9.2 Latin America Apoptosis Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Apoptosis Assays Market Size by Country (2019-2024)
9.4 Latin America Apoptosis Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Apoptosis Assays Market Size (2019-2030)
10.2 Middle East & Africa Apoptosis Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Apoptosis Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Apoptosis Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Apoptosis Assays Introduction
11.1.4 Merck Revenue in Apoptosis Assays Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Apoptosis Assays Introduction
11.2.4 Thermo Fisher Scientific Revenue in Apoptosis Assays Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Apoptosis Assays Introduction
11.3.4 Becton Dickinson Revenue in Apoptosis Assays Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Apoptosis Assays Introduction
11.4.4 Bio-Rad Laboratories Revenue in Apoptosis Assays Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Detail
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Apoptosis Assays Introduction
11.5.4 Promega Corporation Revenue in Apoptosis Assays Business (2019-2024)
11.5.5 Promega Corporation Recent Development
11.6 Abcam
11.6.1 Abcam Company Detail
11.6.2 Abcam Business Overview
11.6.3 Abcam Apoptosis Assays Introduction
11.6.4 Abcam Revenue in Apoptosis Assays Business (2019-2024)
11.6.5 Abcam Recent Development
11.7 Bio-Techne
11.7.1 Bio-Techne Company Detail
11.7.2 Bio-Techne Business Overview
11.7.3 Bio-Techne Apoptosis Assays Introduction
11.7.4 Bio-Techne Revenue in Apoptosis Assays Business (2019-2024)
11.7.5 Bio-Techne Recent Development
11.8 Sartorius
11.8.1 Sartorius Company Detail
11.8.2 Sartorius Business Overview
11.8.3 Sartorius Apoptosis Assays Introduction
11.8.4 Sartorius Revenue in Apoptosis Assays Business (2019-2024)
11.8.5 Sartorius Recent Development
11.9 Biotium
11.9.1 Biotium Company Detail
11.9.2 Biotium Business Overview
11.9.3 Biotium Apoptosis Assays Introduction
11.9.4 Biotium Revenue in Apoptosis Assays Business (2019-2024)
11.9.5 Biotium Recent Development
11.10 Creative Bioarray
11.10.1 Creative Bioarray Company Detail
11.10.2 Creative Bioarray Business Overview
11.10.3 Creative Bioarray Apoptosis Assays Introduction
11.10.4 Creative Bioarray Revenue in Apoptosis Assays Business (2019-2024)
11.10.5 Creative Bioarray Recent Development
11.11 Geno Technology
11.11.1 Geno Technology Company Detail
11.11.2 Geno Technology Business Overview
11.11.3 Geno Technology Apoptosis Assays Introduction
11.11.4 Geno Technology Revenue in Apoptosis Assays Business (2019-2024)
11.11.5 Geno Technology Recent Development
11.12 GeneCopoeia
11.12.1 GeneCopoeia Company Detail
11.12.2 GeneCopoeia Business Overview
11.12.3 GeneCopoeia Apoptosis Assays Introduction
11.12.4 GeneCopoeia Revenue in Apoptosis Assays Business (2019-2024)
11.12.5 GeneCopoeia Recent Development
11.13 Danaher
11.13.1 Danaher Company Detail
11.13.2 Danaher Business Overview
11.13.3 Danaher Apoptosis Assays Introduction
11.13.4 Danaher Revenue in Apoptosis Assays Business (2019-2024)
11.13.5 Danaher Recent Development
11.14 GE Healthcare
11.14.1 GE Healthcare Company Detail
11.14.2 GE Healthcare Business Overview
11.14.3 GE Healthcare Apoptosis Assays Introduction
11.14.4 GE Healthcare Revenue in Apoptosis Assays Business (2019-2024)
11.14.5 GE Healthcare Recent Development
11.15 PerkinElmer
11.15.1 PerkinElmer Company Detail
11.15.2 PerkinElmer Business Overview
11.15.3 PerkinElmer Apoptosis Assays Introduction
11.15.4 PerkinElmer Revenue in Apoptosis Assays Business (2019-2024)
11.15.5 PerkinElmer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’